Highest-materiality recent filing
Zevia amends credit facility: maturity extended to Feb 2030, spread reduced
Maturity of revolving credit line extended to February 22, 2030.
Zevia Q1 net sales up 21% to $46.1M, adjusted EBITDA positive at $0.9M
Net sales $46.1M (+21.2% YoY); driven by 20.4% volume growth, led by Club, Mass, and E-commerce.
Zevia Q4 loss narrows to $1.3M; guides FY2026 rev $169M-$173M, near breakeven EBITDA
Q4 net sales $37.9M (-4% YoY); net loss $1.3M vs $6.8M loss YoY; Adj EBITDA ~$50K vs -$3.9M loss.
Zevia PBC appoints Suzanne Ginestro to Board; Justin Shaw to step down Feb 24, 2026
Suzanne Ginestro, CMO of Califia Farms, appointed as independent Class II director and Compensation Committee member effective Jan 7, 2026.
Zevia Q3 net sales up 12.3% to $40.8M; Adj. EBITDA loss $1.7M; guides FY2025 sales $162-164M
Net sales grew 12.3% to $40.8M driven by 12.6% volume growth from expanded Walmart & Club distribution.
Zevia posts investor presentation on website; no specific details visible in filing
Investor presentation posted August 25, 2025, to investors.zevia.com.
Zevia PBC enters ATM equity facility with Piper Sandler for up to $20 million
ATM agreement allows sale of up to $20M of Class A common stock; Piper Sandler acts as sales agent.
Zevia Q2 net sales $44.5M (+10.1% YoY); posts positive adj. EBITDA of $0.2M
Net sales grew 10.1% to $44.5M on volume growth of 14.3%; gross margin expanded 680 bps to 48.7%.
Director Rosemary Ripley resigns from Zevia Board; three Class I directors re-elected
Rosemary Ripley resigned effective June 12, 2025; no disagreement with the company or Board.
On June 12, 2025, Rosemary Ripley, a member of the Board of Directors (the “Board”) of Zevia PBC (the “Company”), notified the Company that she will be stepping down from the Board, effective as of June 12, 2025.
Max materiality 0.70 · Median 0.50 · Most common event earnings